Cargando…

Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers

Background: Understanding patient and caregiver preferences for treatment is important for optimizing treatment decisions. Non-stimulant therapies are an alternative treatment option to stimulant therapy for attention-deficit/hyperactivity disorder (ADHD). Guanfacine extended release (GXR) and atomo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flood, Emuella, Gajria, Kavita, Sikirica, Vanja, Hodgkins, Paul, Erder, M. Haim, Lopez, Frank, Connor, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2016
Materias:	Psychological Conditions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471410/ https://www.ncbi.nlm.nih.gov/pubmed/37662653 http://dx.doi.org/10.36469/9842

Ejemplares similares

Unmet Needs Associated with Attention-Deficit/Hyperactivity Disorder in Eight European Countries as Reported by Caregivers and Adolescents: Results from Qualitative Research
por: Sikirica, Vanja, et al.
Publicado: (2014)

Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Sikirica, Vanja, et al.
Publicado: (2013)

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe
por: Fridman, Moshe, et al.
Publicado: (2017)

Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder
por: Gajria, Kavita, et al.
Publicado: (2015)

Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control
por: Fridman, Moshe, et al.
Publicado: (2017)

Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
por: Sikirica, Vanja, et al.
Publicado: (2012)

Is it Attention Deficit Hyperactivity Disorder (ADHD) or Stimulant use disorder ? How is ADHD diagnosed?
por: Sud, N.
Publicado: (2022)

Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case
por: Le, Hoa H., et al.
Publicado: (2013)

Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
por: Gajria, Kavita, et al.
Publicado: (2014)

Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”
por: Erder, M. Haim, et al.
Publicado: (2013)

Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology
por: Sikirica, Vanja, et al.
Publicado: (2013)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009)

Comparative Treatment Patterns, Resource Utilization, and Costs in Stimulant-Treated Children with ADHD Who Require Subsequent Pharmacotherapy with Atypical Antipsychotics Versus Non-Antipsychotics
por: Sikirica, Vanja, et al.
Publicado: (2012)

Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
por: Lachaine, Jean, et al.
Publicado: (2016)

Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers
por: Advokat, Claire, et al.
Publicado: (2013)

Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD)
por: Schmidt, Sören, et al.
Publicado: (2009)

Emotional dysregulation and attention deficit hyperactivity disorder (ADHD)
por: Turkia, I. Ben, et al.
Publicado: (2021)

Emotional Intelligence and Attention-deficit/hyperactivity disorder (ADHD)
por: Ben Turkia, I., et al.
Publicado: (2023)

Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experiment
por: Mühlbacher, Axel C, et al.
Publicado: (2009)

Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany
por: Kotsopoulos, Nikolaos, et al.
Publicado: (2013)

Attention-Deficit/Hyperactivity Disorder (ADHD) and High Risk Behaviors
por: Bakhshani, Nour-Mohammad
Publicado: (2013)

Dietary Patterns in Children with Attention Deficit/Hyperactivity Disorder (ADHD)
por: Woo, Hae Dong, et al.
Publicado: (2014)

Attention-Deficit/Hyperactivity Disorder (ADHD) and Obesity: Update 2016
por: Cortese, Samuele, et al.
Publicado: (2017)

Personality profiles in adults with attention deficit hyperactivity disorder (ADHD)
por: Perroud, Nader, et al.
Publicado: (2016)

A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)
por: Luo, Yuyang, et al.
Publicado: (2019)

Arousal and Executive Alterations in Attention Deficit Hyperactivity Disorder (ADHD)
por: Martella, Diana, et al.
Publicado: (2020)

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review
por: Rubia, Katya, et al.
Publicado: (2021)

Yoga as an Adjunct Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
por: Srinivas, S., et al.
Publicado: (2023)

Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Moon, Su Jin, et al.
Publicado: (2014)

Shared Genetic Influences Between Attention-Deficit/Hyperactivity Disorder (ADHD) Traits in Children and Clinical ADHD
por: Stergiakouli, Evie, et al.
Publicado: (2015)

Joint polygenic and environmental risks for childhood attention‐deficit/hyperactivity disorder (ADHD) and ADHD symptom dimensions
por: Mooney, Michael A., et al.
Publicado: (2023)

The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care
por: McCarthy, Suzanne, et al.
Publicado: (2012)

Executive and motivational processes in adolescents with Attention-Deficit-Hyperactivity Disorder (ADHD)
por: Toplak, Maggie E, et al.
Publicado: (2005)

Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies
por: Parens, Erik, et al.
Publicado: (2009)

Genetic Epidemiology of Attention Deficit Hyperactivity Disorder (ADHD Index) in Adults
por: Boomsma, Dorret I., et al.
Publicado: (2010)

Prevalence of Adult Attention Deficit Hyperactivity Disorder (Adult ADHD): Tabriz
por: Amiri, Shahrokh, et al.
Publicado: (2014)

Pediatric Integrative Medicine Approaches to Attention Deficit Hyperactivity Disorder (ADHD)
por: Esparham, Anna, et al.
Publicado: (2014)

The association between attention-deficit/hyperactivity (ADHD) symptoms and self-employment
por: Verheul, Ingrid, et al.
Publicado: (2016)

On the Temporal Characteristics of Performance Variability in Attention Deficit Hyperactivity Disorder (ADHD)
por: Feige, Bernd, et al.
Publicado: (2013)

Attention Deficit/Hyperactivity Disorder (ADHD) Diagnosis: An Activation-Executive Model
por: Rodríguez, Celestino, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_halsnaoljurooan6tcp2fohqqq